Cipher Pharmaceuticals Inc
SWB:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Cipher Pharmaceuticals Inc (PHE) under the Base Case is EUR per share.
Compared with the current market price of 8.65 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Cipher Pharmaceuticals Does
Cipher Pharmaceuticals is a specialty drug company that focuses on dermatology and a small number of other prescription products. It does not run a large research lab or a broad drug factory network. Instead, it buys or licenses medicines that already exist or are close to market, then develops, registers, and sells them in the markets where it thinks they can win a place.
- Headquarters
- Canada CA
- Employees
- 43
- IPO date
- Feb 25, 2004
Revenue & Expenses Breakdown
Cipher Pharmaceuticals Inc
Earnings Waterfall
Cipher Pharmaceuticals Inc
What is the Intrinsic Value of one PHE stock?
The intrinsic value for Cipher Pharmaceuticals Inc (PHE) under the Base Case is EUR.
Is PHE stock undervalued or overvalued?
Compared with the current market price of 8.65 EUR, the stock appears .
